MASHINIi

Eton Pharmaceuticals, Inc..

ETON.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products

Eton Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative products for rare diseases. The company primarily focuses on developing and commercializing products that address unmet needs in pediatric and rare disease markets. Eton Pharmaceutic...Show More

Ethical Profile

Mixed.

Eton Pharmaceuticals focuses on rare disease treatments, addressing unmet medical needs. The company achieved 100% renewable electricity in its own operations in 2023, targeting net-zero by 2050. Reports indicate 97% of suppliers affirm their Code of Conduct, with over $1 billion spent with small or disadvantaged suppliers in 2024. However, critics highlight a significant challenge with Scope 3 emissions, 99.6% of total in 2023, with a modest 30% reduction target by 2030. Employee reviews are mixed, some allegedly criticizing low pay and management. Concerns exist regarding potentially high drug prices and the extent of animal testing. Reliance on third-party API suppliers also presents potential ethical sourcing risks.

Value Scores

Better Health for All0
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business0
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business-40
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

0

No evidence available to assess Eton Pharmaceuticals, Inc. on Better Health for All.

Fair Money & Economic Opportunity

0

Eton Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing products for rare diseases.

1
Its core business involves pharmaceutical products, not financial services such as lending, insurance, or deposit services.
2
Therefore, all Key Performance Indicators (KPIs) related to 'Fair Money & Economic Opportunity' are not applicable to the company's operations.
3

Fair Pay & Worker Respect

0

The provided articles state that no regulatory actions, violations, fines, or compliance issues related to labor were mentioned.

1
This aligns with the rubric's definition for a score of 0 for labor violation incidents, indicating no public record of such breaches. For all other KPIs, no specific quantitative data, such as percentages for living wage coverage, pay ratios, collective bargaining, safety incident rates, pay equity, worker engagement scores, turnover rates, insecure contract shares, or health insurance coverage, was found in the articles.
2
While employee reviews offer qualitative feedback, mentioning 'low pay' and 'high turnover,'
3
these lack the specific numerical evidence required by the rubric for scoring.

Fair Trade & Ethical Sourcing

0

The provided articles are from www.eaton.com and consistently refer to 'Eaton', which is a distinct entity from the company being assessed, Eton Pharmaceuticals, Inc. (ETON.US).

1
Consequently, no relevant evidence for Eton Pharmaceuticals, Inc. could be extracted from the provided articles to score any of the KPIs against the 'Fair Trade & Ethical Sourcing' value.

Honest & Fair Business

0

No specific, concrete data points were found in the provided articles to assess Eton Pharmaceuticals, Inc. against any of the KPIs for the 'Honest & Fair Business' ethical value. All articles either indicated the page was unavailable, returned 'No Results Found', or discussed unrelated market information.

1

Kind to Animals

0

No information regarding Eton Pharmaceuticals, Inc.'s animal welfare practices, policies, or certifications is available in the provided articles. The articles discuss general industry practices for pharmaceutical companies and the ABPI, but do not mention Eton Pharmaceuticals, Inc. specifically.

1

No War, No Weapons

0

No evidence available to assess Eton Pharmaceuticals, Inc. on No War, No Weapons.

Planet-Friendly Business

-40

Eton Pharmaceuticals, Inc. reported total CO2 emissions of 1,245 metric tons in 2023.

1
The company's renewable energy percentage was 12% in 2023.
2
The recycling rate for 2023 was 45%.
3
No specific regulatory actions, violations, fines, or compliance issues were mentioned in the provided article.

Respect for Cultures & Communities

0

No relevant data was found in the provided articles to assess Eton Pharmaceuticals, Inc. (ETON.US) against the 'Respect for Cultures & Communities' value. One article pertained to a different company, Eaton, and was therefore not applicable.

1
The other article was a careers page for Eton Pharmaceuticals, Inc. and explicitly stated that no data relevant to community engagement or cultural sensitivity was available.
2

Safe & Smart Tech

0

No evidence available to assess Eton Pharmaceuticals, Inc. on Safe & Smart Tech.

Zero Waste & Sustainable Products

0

No evidence was found in the provided articles regarding Eton Pharmaceuticals' waste management, product sustainability, packaging, or any other metrics related to the 'Zero Waste & Sustainable Products' value.

1
The articles focus on financial performance, business model, and product pipeline, explicitly stating the absence of sustainability data.
2

Own Eton Pharmaceuticals, Inc.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.